(OR) L’Oreal - Ratings and Ratios
Skincare, Makeup, Haircare, Perfumes, Hygiene
Dividends
| Dividend Yield | 1.92% |
| Yield on Cost 5y | 2.50% |
| Yield CAGR 5y | 14.42% |
| Payout Consistency | 95.0% |
| Payout Ratio | 61.3% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 22.2% |
| Value at Risk 5%th | 35.4% |
| Relative Tail Risk | -2.94% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.26 |
| Alpha | 3.50 |
| CAGR/Max DD | 0.14 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.518 |
| Beta | 0.127 |
| Beta Downside | -0.035 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.92% |
| Mean DD | 11.30% |
| Median DD | 10.37% |
Description: OR L’Oreal December 02, 2025
LOréal S.A. (ticker OR) is a French multinational that designs, manufactures and markets a broad portfolio of cosmetics and personal-care products for both women and men. The business is organized into four divisions-Professional Products, Consumer Products, Luxe, and Dermatological Beauty-covering categories such as skincare, makeup, hair colour, haircare, fragrances and hygiene.
In FY 2023 the group generated roughly €38 billion in revenue, with an operating margin of about 16 % and e-commerce sales expanding ~20 % year-over-year, reflecting the accelerating shift toward online purchasing. Key growth drivers include rising demand for premium and “clean-beauty” formulations, sustained spending in emerging markets (particularly China and India), and the continued rollout of sustainability initiatives that resonate with environmentally-aware consumers.
LOréal distributes its products through a diversified network that includes hair salons, mass-market retailers, department-store perfumeries, pharmacies, drugstores, travel-retail outlets, e-commerce platforms, and stand-alone concept stores, allowing it to capture demand across multiple consumer touchpoints.
For a deeper, data-driven assessment of LOréal’s valuation and risk profile, you may find the ValueRay analysis worth a look.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (11.21b TTM) > 0 and > 6% of Revenue (6% = 4.61b TTM) |
| FCFTA 0.17 (>2.0%) and ΔFCFTA 2.60pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 3.75% (prev 3.46%; Δ 0.28pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.22 (>3.0%) and CFO 11.79b > Net Income 11.21b (YES >=105%, WARN >=100%) |
| Net Debt (4.01b) to EBITDA (18.35b) ratio: 0.22 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.19 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (535.4m) change vs 12m ago NaN% (target <= -2.0% for YES) |
| Gross Margin 73.80% (prev 73.89%; Δ -0.08pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 144.3% (prev 79.42%; Δ 64.83pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 27.45 (EBITDA TTM 18.35b / Interest Expense TTM 568.0m) >= 6 (WARN >= 3) |
Altman Z'' 4.91
| (A) 0.05 = (Total Current Assets 18.28b - Total Current Liabilities 15.40b) / Total Assets 54.60b |
| (B) 0.41 = Retained Earnings (Balance) 22.26b / Total Assets 54.60b |
| (C) 0.29 = EBIT TTM 15.59b / Avg Total Assets 53.23b |
| (D) 1.21 = Book Value of Equity 28.23b / Total Liabilities 23.42b |
| Total Rating: 4.91 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 77.73
| 1. Piotroski 6.0pt |
| 2. FCF Yield 4.61% |
| 3. FCF Margin 12.22% |
| 4. Debt/Equity 0.28 |
| 5. Debt/Ebitda 0.22 |
| 6. ROIC - WACC (= 22.89)% |
| 7. RoE 36.45% |
| 8. Rev. Trend 15.33% |
| 9. EPS Trend 5.90% |
What is the price of OR shares?
Over the past week, the price has changed by -3.33%, over one month by +3.22%, over three months by -9.15% and over the past year by +6.37%.
Is OR a buy, sell or hold?
What are the forecasts/targets for the OR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 388.4 | 6.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 358.4 | -1.9% |
OR Fundamental Data Overview November 27, 2025
Market Cap EUR = 199.58b (199.58b EUR * 1.0 EUR.EUR)
P/E Trailing = 32.7408
P/E Forward = 26.5252
P/S = 4.5526
P/B = 6.2868
P/EG = 4.0536
Beta = 0.904
Revenue TTM = 76.78b EUR
EBIT TTM = 15.59b EUR
EBITDA TTM = 18.35b EUR
Long Term Debt = 4.76b EUR (from longTermDebt, last quarter)
Short Term Debt = 2.64b EUR (from shortTermDebt, last quarter)
Debt = 8.83b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.01b EUR (from netDebt column, last quarter)
Enterprise Value = 203.59b EUR (199.58b + Debt 8.83b - CCE 4.82b)
Interest Coverage Ratio = 27.45 (Ebit TTM 15.59b / Interest Expense TTM 568.0m)
FCF Yield = 4.61% (FCF TTM 9.39b / Enterprise Value 203.59b)
FCF Margin = 12.22% (FCF TTM 9.39b / Revenue TTM 76.78b)
Net Margin = 14.60% (Net Income TTM 11.21b / Revenue TTM 76.78b)
Gross Margin = 73.80% ((Revenue TTM 76.78b - Cost of Revenue TTM 20.11b) / Revenue TTM)
Gross Margin QoQ = 74.67% (prev 70.48%)
Tobins Q-Ratio = 3.73 (Enterprise Value 203.59b / Total Assets 54.60b)
Interest Expense / Debt = 2.05% (Interest Expense 181.0m / Debt 8.83b)
Taxrate = 28.47% (1.34b / 4.71b)
NOPAT = 11.15b (EBIT 15.59b * (1 - 28.47%))
Current Ratio = 1.19 (Total Current Assets 18.28b / Total Current Liabilities 15.40b)
Debt / Equity = 0.28 (Debt 8.83b / totalStockholderEquity, last quarter 31.18b)
Debt / EBITDA = 0.22 (Net Debt 4.01b / EBITDA 18.35b)
Debt / FCF = 0.43 (Net Debt 4.01b / FCF TTM 9.39b)
Total Stockholder Equity = 30.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 20.53% (Net Income 11.21b / Total Assets 54.60b)
RoE = 36.45% (Net Income TTM 11.21b / Total Stockholder Equity 30.75b)
RoCE = 43.91% (EBIT 15.59b / Capital Employed (Equity 30.75b + L.T.Debt 4.76b))
RoIC = 29.16% (NOPAT 11.15b / Invested Capital 38.25b)
WACC = 6.27% (E(199.58b)/V(208.41b) * Re(6.48%) + D(8.83b)/V(208.41b) * Rd(2.05%) * (1-Tc(0.28)))
Discount Rate = 6.48% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.14%
[DCF Debug] Terminal Value 81.33% ; FCFE base≈8.66b ; Y1≈10.61b ; Y5≈17.81b
Fair Price DCF = 568.2 (DCF Value 303.28b / Shares Outstanding 533.8m; 5y FCF grow 24.08% → 3.0% )
EPS Correlation: 5.90 | EPS CAGR: 12.98% | SUE: 0.0 | # QB: 0
Revenue Correlation: 15.33 | Revenue CAGR: 18.99% | SUE: 0.81 | # QB: 0
EPS next Year (2026-12-31): EPS=13.63 | Chg30d=+0.014 | Revisions Net=-6 | Growth EPS=+6.2% | Growth Revenue=+4.2%